Verrica Pharmaceuticals Inc.

DB:1NE Stock Report

Market Cap: €43.4m

Verrica Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:1NE Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
27 Aug 24Sell€69,392P. Terence KohlerIndividual29,719€2.38
27 Aug 24Sell€31,493Gary GoldenbergIndividual13,489€2.38
27 Aug 24Sell€78,686Joe BonaccorsoIndividual33,702€2.38
27 Aug 24Sell€83,381Christopher HayesIndividual35,713€2.38
27 Aug 24Sell€79,391Ted WhiteIndividual34,000€2.38
23 Jul 24Sell€141,383Christopher HayesIndividual21,740€6.50
23 Jul 24Sell€166,329Joe BonaccorsoIndividual25,576€6.50
23 Jul 24Sell€120,357Gary GoldenbergIndividual18,507€6.50
23 Jul 24Sell€212,158Ted WhiteIndividual32,623€6.50
29 Dec 23Buy€2,085,453Perceptive Advisors LLCCompany321,616€6.55
26 Dec 23Buy€2,951,412Perceptive Advisors LLCCompany504,652€6.05
19 Dec 23Buy€6,323,209Perceptive Advisors LLCCompany1,233,931€5.44

Insider Trading Volume

Insider Buying: 1NE insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of 1NE?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms7,099,18215.6%
Institutions8,209,21118%
Individual Insiders14,841,56132.5%
General Public15,450,84133.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.4%.


Top Shareholders

Top 25 shareholders own 62.72% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
29.7%
Paul Manning
13,549,056€12.9m-11.6%no data
15.6%
Perceptive Advisors LLC
7,099,182€6.7m0%0.14%
2.82%
The Vanguard Group, Inc.
1,286,600€1.2m1.35%no data
2.38%
BlackRock, Inc.
1,085,439€1.0m-3.87%no data
1.39%
FMR LLC
632,283€601.1k-43%no data
1.23%
Jayson Rieger
558,983€531.4k116%no data
1.12%
State Street Global Advisors, Inc.
512,821€487.5k13.5%no data
1.01%
Sean Stalfort
462,110€439.3k0%no data
1%
Geode Capital Management, LLC
455,480€433.0k-1.7%no data
0.76%
Propel Bio Management, LLC
344,937€327.9k138%0.19%
0.71%
Qube Research & Technologies Ltd
322,186€306.3k0%no data
0.56%
PBM Capital Group LLC
256,634€244.0k0%1.99%
0.51%
XTX Holdings Limited, Asset Management Arm
231,148€219.7k0%0.01%
0.48%
Northern Trust Global Investments
219,104€208.3k14.9%no data
0.44%
Simplify Asset Management Inc.
200,000€190.1k-28.6%0.01%
0.41%
ExodusPoint Capital Management, LP
186,132€177.0k0%no data
0.39%
BML Capital Management, LLC
180,000€171.1k0%0.08%
0.38%
DWS Investment Management Americas, Inc.
174,700€166.1k0%no data
0.35%
Morgan Stanley, Investment Banking and Brokerage Investments
160,067€152.2k143%no data
0.32%
Renaissance Technologies LLC
147,964€140.7k225%no data
0.25%
Two Sigma Investments, LP
115,284€109.6k169%no data
0.25%
Wellington Management Group LLP
114,363€108.7k-4.63%no data
0.23%
Ted White
103,467€98.4k-39.2%no data
0.22%
SteelPeak Wealth, LLC
101,998€97.0k-17%no data
0.22%
Kovitz Investment Group Partners, LLC
101,125€96.1k1%no data